CVS Health's basic earnings per share (Basic EPS) for the
three
months ended in Mar. 2026 was R$1.21.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was R$1.24.
CVS Health's EPS (Diluted) for the
three
months ended in Mar. 2026 was R$1.20.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was R$1.22.
CVS Health's EPS without NRI for the
three
months ended in Mar. 2026 was R$1.34.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 3.80.
During the past 12 months, CVS Health's average EPS without NRIGrowth Rate was 19.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 27.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -2.40% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 2.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, CVS Health's highest 3-Year average EPS without NRI Growth Rate was 35.10% per year. The lowest was -40.50% per year. And the median was 11.70% per year.
CVS Health (BSP:CVSH34) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
CVS Health EPS (Basic) Related Terms
CVS Health EPS (Basic) Historical Data
* Premium members only.
The historical data trend for CVS Health's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
CVS Health's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Health (BSP:CVSH34) has a EPS (Basic) of R$1.24 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on CVS Health and its competitors.
Is CVS Health's EPS (Basic) too high?
CVS Health's current EPS (Basic) is R$1.24. Overall, CVS Health has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's EPS (Basic) compare to ELV and CI?
CVS Health's EPS (Basic) of R$1.24 can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Plans company?
A good EPS (Basic) depends on the Healthcare Plans industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on CVS Health and its competitors. CVS Health's current EPS (Basic) is R$1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (BSP:CVSH34) is currently considered Significantly Overvalued. The stock's GF Value™ is R$40.19, compared to a current price of R$52.70 — trading 31.1% above its estimated fair value. The current EPS (Basic) is R$1.24. CVS Health's overall GF Score™ is 68/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For CVS Health (BSP:CVSH34), the current EPS (Basic) is R$1.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Health (BSP:CVSH34) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Health stock appears to be overvalued.
The current stock price of R$52.70 is trading 31.1% above its estimated GF Value™ of R$40.19.
GuruFocus considers CVS Health to be Significantly Overvalued.
Key valuation signals for BSP:CVSH34:
EPS (Basic): R$1.24
GF Value™: R$40.19 vs. price of R$52.70 (31.1% above fair value)
No single metric tells the full story. See the BSP:CVSH34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
68GF Score
Get the complete analysis for BSP:CVSH34
EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:CVSH34 has been successfully added to your 
